Radiation Oncology at University of Colorado Hospital.
Radiation Oncology
Dr. Laurie E. Gaspar, MD
|
|
Give Review
Doctor Laurie E. Gaspar, MD practices Radiation Oncology. He has 2 awards "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Laurie Gaspar is a published doctor as well. He has 23 publications published. The latest was: Neoadjuvant combination chemotherapy for unresectable stage III non-small cell lung cancer. He is registered with Medicare and accepts Medicare payments.
Publications
- Neoadjuvant combination chemotherapy for unresectable stage III non-small cell lung cancer.
- Lung deformations and radiation-induced regional lung collapse in patients treated with stereotactic body radiation therapy.
- Clinical Validation of 4-Dimensional Computed Tomography Ventilation With Pulmonary Function Test Data.
- Phase II Trial of Stereotactic Body Radiation Therapy Combined With Erlotinib for Patients With Limited but Progressive Metastatic Non-Small-Cell Lung Cancer.
- Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma.
- The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population.
- Hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy may alter the patterns of failure in patients with glioblastoma multiforme.
- Comparison of 4-dimensional computed tomography ventilation with nuclear medicine ventilation-perfusion imaging: a clinical validation study.
- Stereotactic Radiation Therapy can Safely and Durably Control Sites of Extra-Central Nervous System Oligoprogressive Disease in Anaplastic Lymphoma Kinase-Positive Lun...
- Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide.
- Spatial and dose-response analysis of fibrotic lung changes after stereotactic body radiation therapy.
- TH-C-213AB-01: Spatial and Dose-Response Analysis of Fibrotic Lung Changes After Stereotactic Body Radiation Therapy.
- WE-A-217A-05: Lung Deformations and Airway Stenosis with Distal Atelectasis in Patients Treated with Stereotactic Body Radiation Therapy for Lung Tumors.
- Regional Normal Lung Tissue Density Changes in Patients Treated With Stereotactic Body Radiation Therapy for Lung Tumors.
- Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
- Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
- Radiographic and histopathologic observations after combined EGFR inhibition and hypofractionated stereotactic radiosurgery in patients with recurrent malignant gliomas.
- Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy.
- Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy.
- Stereotactic Body Radiation Therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review.
- Dosimetric errors during treatment of centrally located lung tumors with stereotactic body radiation therapy: Monte Carlo evaluation of tissue inhomogeneity corrections.
- Effect of induction chemotherapy on estimated risk of radiation pneumonitis in bulky non-small cell lung cancer.
Schools
The University Of Western OntarioSchulich School Of Medicine amp Dentistry
The University Of Western Ontario
Doctors Specialties
- Radiation Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Pathway X Bronze Direct CACA IN HIX
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Humana
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Western Ontario
Hospital
-
University of Colorado Hospital
Drug Facts
| NPI NUMBER | 1073620811 | |
| NPPES Provider LastName | GASPAR | |
| NPPES Provider FirstName | LAURIE | |
| NPPES Provider ZIPCode | 800452545 | |
| NPPES Provider State | CO | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 41.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1073620811 |
| Last Name Of The Provider | GASPAR |
| First Name Of The Provider | LAURIE |
| View All |
Similar Doctors
|
Dr. David Raben, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Rachel Rabinovitch, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Arthur K. Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian D. Kavanagh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracey Schefter, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|